[{"AccountsPayableAndAccruedLiabilitiesCurrent_0_FY_USD":5620000.0,"OtherCostAndExpenseOperating_4_FY_USD":0.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_4_FY_USD":11600000.0,"OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_4_FY_USD":50896000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_4_FY_USD":604323000.0,"OtherComprehensiveIncomeLossNetOfTax_4_FY_USD":-39296000.0,"OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax_4_FY_USD":0.0,"OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_4_FY_USD":6335000.0,"OtherAssetsNoncurrent_0_FY_USD":4145000.0,"OtherAssetsCurrent_0_FY_USD":6631000.0,"OperatingIncomeLoss_4_FY_USD":1430715000.0,"NumberOfOperatingSegments_4_FY_segment":1.0,"NotesReceivableNet_0_FY_USD":14332596000.0,"OtherLiabilitiesCurrent_0_FY_USD":0.0,"NotesReceivableGross_0_FY_USD":16027541000.0,"NotesAndLoansReceivableNetCurrent_0_FY_USD":614351000.0,"NonoperatingIncomeExpense_4_FY_USD":-189514000.0,"NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1_4_FY_USD":0.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_4_FY_USD":619728000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_4_FY_USD":619728000.0,"NetIncomeLossAttributableToNoncontrollingInterest_4_FY_USD":621473000.0,"NetIncomeLoss_4_FY_USD":619728000.0,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":2017536000.0,"NetCashProvidedByUsedInInvestingActivities_4_FY_USD":-1870280000.0,"NetCashProvidedByUsedInFinancingActivities_4_FY_USD":385112000.0,"MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_4_FY_USD":614973000.0,"MinorityInterest_0_FY_USD":4471951000.0,"NotesAndLoansReceivableNetNoncurrent_0_FY_USD":13718245000.0,"OtherNoncashIncomeExpense_4_FY_USD":-4461000.0,"OtherNonoperatingIncomeExpense_4_FY_USD":-5678000.0,"PaymentsForRepurchaseOfCommonStock_4_FY_USD":0.0,"UnrealizedGainLossOnDerivatives_4_FY_USD":-21532000.0,"TreasuryStockValue_0_FY_USD":2715000.0,"TradingSecuritiesDebt_0_FY_USD":581872000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_4_FY_USD":2443000.0,"StockholdersEquityOther_4_FY_USD":0.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_FY_USD":10248545000.0,"ShareBasedCompensation_4_FY_USD":2443000.0,"Revenues_4_FY_USD":2289463000.0,"RetainedEarningsAccumulatedDeficit_0_FY_USD":2255179000.0,"ResearchAndDevelopmentExpense_4_FY_USD":200084000.0,"RepaymentsOfLongTermDebt_4_FY_USD":0.0,"ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_4_FY_USD":28481000.0,"ProvisionForLoanLossesExpensed_4_FY_USD":-12913000.0,"ProvisionForLoanAndLeaseLosses_4_FY_USD":452842000.0,"ProfitLoss_4_FY_USD":1241201000.0,"ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_4_FY_USD":62500000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_4_FY_USD":1597851000.0,"ProceedsFromIssuanceOfLongTermDebt_4_FY_USD":1272533000.0,"ProceedsFromIssuanceInitialPublicOffering_4_FY_USD":0.0,"ProceedsFromInterestReceived_4_FY_USD":3135000.0,"ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital_4_FY_USD":523000.0,"PaymentsToMinorityShareholders_4_FY_USD":479604000.0,"PaymentsToAcquireMarketableSecurities_4_FY_USD":1196579000.0,"PaymentsToAcquireFinanceReceivables_4_FY_USD":2191502000.0,"PaymentsToAcquireEquityMethodInvestments_4_FY_USD":34855000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_4_FY_USD":70441000.0,"PaymentsOfDebtIssuanceCosts_4_FY_USD":13046000.0,"LongTermDebtNoncurrent_0_FY_USD":7096070000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":414802000.0,"LongTermDebtCurrent_0_FY_USD":0.0,"LiabilitiesCurrent_0_FY_USD":171250000.0,"DividendsCommonStockCash_4_FY_USD":285200000.0,"DividendsCash_4_FY_USD":285184000.0,"DebtSecuritiesAvailableForSaleUnrealizedGainLoss_4_FY_USD":17859000.0,"DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_0_FY_USD":203930000.0,"CostsAndExpenses_4_FY_USD":858748000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_4_FY_USD":1201905000.0,"ComprehensiveIncomeNetOfTax_4_FY_USD":597582000.0,"CommonStockDividendsPerShareCashPaid_1_FY_USD":0.17,"CommonStockDividendsPerShareCashPaid_4_FY_USD":0.68,"CommitmentsAndContingencies_0_FY_USD":null,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_4_FY_USD":532368000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_FY_USD":1541048000.0,"DueToRelatedPartiesCurrent_0_FY_USD":107934000.0,"CashAndCashEquivalentsAtCarryingValue_0_FY_USD":1541048000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_FY_USD":66000000.0,"AvailableForSaleSecuritiesDebtSecurities_0_FY_USD":270400000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_FY_USD":204509000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_FY_USD":65891000.0,"AssetsCurrent_0_FY_USD":2878211000.0,"Assets_0_FY_USD":17515865000.0,"AssetImpairmentCharges_4_FY_USD":0.0,"AmortizationOfIntangibleAssets_4_FY_USD":22996000.0,"AmortizationOfFinancingCostsAndDiscounts_4_FY_USD":20162000.0,"AllocatedShareBasedCompensationExpense_4_FY_USD":3100000.0,"AdditionalPaidInCapital_0_FY_USD":3507533000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_FY_USD":16491000.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_FY_USD":204400000.0,"DueToRelatedPartiesNoncurrent_0_FY_USD":107934000.0,"EarningsPerShareBasic_4_FY_USD":1.49,"EarningsPerShareDiluted_4_FY_USD":1.49,"LiabilitiesAndStockholdersEquity_0_FY_USD":17515865000.0,"Liabilities_0_FY_USD":7267320000.0,"InvestmentIncomeNet_4_FY_USD":53535000.0,"InterestPayableCurrent_0_FY_USD":57696000.0,"InterestPaidNet_4_FY_USD":130430000.0,"InterestExpense_4_FY_USD":166142000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_4_FY_shares":8000.0,"IncreaseDecreaseInOtherReceivables_4_FY_USD":0.0,"IncreaseDecreaseInOtherCurrentAssets_4_FY_USD":-1857000.0,"IncreaseDecreaseInInterestPayableNet_4_FY_USD":15550000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_4_FY_USD":-4586000.0,"IncomeTaxExpenseBenefit_4_FY_USD":0.0,"IncomeLossFromEquityMethodInvestments_4_FY_USD":-19490000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4_FY_USD":1241201000.0,"GeneralAndAdministrativeExpense_4_FY_USD":182826000.0,"GainsLossesOnExtinguishmentOfDebt_4_FY_USD":-358000.0,"GainLossOnDerivativeInstrumentsNetPretax_4_FY_USD":-21532000.0,"FiniteLivedIntangibleAssetsNet_0_FY_USD":5670000.0,"FiniteLivedIntangibleAssetsGross_0_FY_USD":606216000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_FY_USD":600546000.0,"FinancingReceivableChangeInPresentValueExpenseReversal_4_FY_USD":-21721000.0,"FinancingReceivableAllowanceForCreditLosses_0_FY_USD":1694945000.0,"FairValueAssetLiabilityRecurringBasisStillHeldUnrealizedGainLoss_4_FY_USD":-60100000.0,"EquitySecuritiesFvNiUnrealizedGainLoss_4_FY_USD":-48066000.0,"EquitySecuritiesFVNINoncurrent_0_FY_USD":269800000.0,"EquityMethodInvestments_0_FY_USD":435394000.0,"EquityMethodInvestmentDividendsOrDistributions_4_FY_USD":34384000.0,"LongTermDebt_0_FY_USD":7096070000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":414794000.0,"Ticker":"RPRX","CIK":"1802768","name":"ROYALTY PHARMA PLC","OfficialName":"Royalty Pharma plc Class A Ordinary Shares ","form":"10-K","period":"20211231","fy":"2021.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"19213987432.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20220215"}]